Veranika Razhkova is an Analyst on the Biotherapeutics team at Deerfield and joined the Firm in 2015 as a Fellow. She provides extensive research and analysis on early-stage investments. Prior to joining the Biotherapeutics group, Ms. Razhkova worked on patient forecasting in the Deerfield Institute. She holds a B.A. in Natural Sciences from The City University of New York’s Baruch College and M.S. in Biotechnology from Johns Hopkins University.
Wenxi Chen is an Analyst on the Medical Devices team at Deerfield and joined the Firm in 2015 as a Fellow. Prior to joining the Devices team, Ms. Chen spent two years working in the Deerfield Institute, where she conducted market research across all sectors of the healthcare industry. Ms. Chen holds a B.S. in Finance from The City University of New York’s Baruch College.